HAS Corporate Logo HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources
Contact Us
  • Sun images
  • Vector Images
HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources

Navigate HTA Challenges with Proven Strategies for Success

Maximising Your MedTech Innovation's Impact through Strategic NICE HTA Submissions

NICE HTA Strategy and Submission - Services | HAS

Navigate the complexities of NICE Health Technology Assessment (HTA) submissions with our expert strategic guidance. Our dedicated team at Health Analytical Solutions leverages in-depth knowledge of the UK healthcare landscape to develop compelling submissions and effective strategies. With a focus on aligning your medtech innovations with NICE guidelines and priorities, we ensure your products stand the best chance of a successful evaluation, enhancing patient access and market impact.

  • Expert Guidance: Benefit from our extensive experience in crafting and managing NICE HTA submissions, reducing complexity and increasing submission success rates.
  • Strategic Alignment: Our strategies are meticulously designed to align with NICE criteria and NHS priorities, ensuring your innovation meets essential healthcare needs.
  • Accelerated Access: Streamline your product's journey to the market with strategies that navigate regulatory pathways efficiently.
  • Stakeholder Engagement: Leverage our expertise in engaging key stakeholders, enhancing the credibility and reception of your submission.
  • Continuous Support: From initial assessment to post-submission, receive comprehensive support throughout the entire HTA process.

Q: How long does the NICE HTA submission process take?
A: The timeline can vary significantly depending on the complexity of the submission and the specific NICE programme. Our team ensures a streamlined process, focusing on efficiency without compromising on quality.

Q: What makes a successful NICE HTA submission?
A: Success hinges on a robust evidence base, clear value proposition, and alignment with NICE methodologies and priorities. Our approach integrates these elements to enhance the likelihood of a positive outcome.

Q: Can you help with resubmissions or appeals?
A: Absolutely. We provide strategic support for resubmissions and appeals, applying insights gained from initial feedback to strengthen your case and address NICE's concerns.

Q: How do you stay updated with NICE guidelines and criteria?
A: Our team continuously monitors updates from NICE and participates in relevant training and events to ensure our strategies are informed by the latest guidelines and best practices.

Enhancing Your Market Access Strategy: Our Additional Services

Stakeholder Engagement for Health Technologies

Stakeholder Engagement for Health Technologies

In the complex ecosystem of healthcare, effectively engaging with key stakeholders is fundamental to the…

Read More
Value Proposition Development for MedTech

Value Proposition Development for MedTech

Unlock the potential of your MedTech innovation with our Value Proposition Development service. At Health…

Read More
Evidence Generation and Management

Evidence Generation and Management

In the MedTech sector, the value of an innovation is increasingly measured not just by…

Read More
Reimbursement Strategy and Support

Reimbursement Strategy and Support

Reimbursement Support, tailored for the complex NHS landscape, aids medical device and life sciences companies…

Read More

Our Latest Insights.

 
  • Richard Tuson

Chapter One: Re-listing or Removed – Renewal Comes to the NHS Drug Tariff Part IX (2025) Device Listing

 
  • Richard Tuson

Life Sciences Sector Plan Chapter Three: NHS Reform and Uptake

 
  • Richard Tuson

Life Sciences Sector Plan Chapter One: Innovation to Adoption

 
  • Richard Tuson

Life Sciences Sector Plan Chapter Two: Growth and Investment

Health Analytical Solutions

  • About
  • Services
  • Blog
  • Resources
  • Contact Us

Services

  • Market Access Analytics and Insight
  • NICE HTA Strategy and Submission
  • Health Economics and Outcomes Research (HEOR)
  • Strategy Development
  • Reimbursement Strategy and Support
  • NHS Drug Tariff Submission Support
  • Private healthcare
  • Value Proposition Development for MedTech
  • Primary Care Market Insights
  • Stakeholder Engagement for Health Technologies
  • Sustainability and NET Zero for MedTech
  • Evidence Generation and Management
  • Dashboard Tools for Market Access
  • MedTech Sales Team Empowerment
  • NHS MedTech Business Case Formulation

Stay Up To Date

  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Contact Us

© Health Analytical Solutions 2025